Default company panoramic image
Logo

Nanospectra Biosciences

Commercialization of a unique nanotechnology-based cancer therapy that allows focused ablation of tumors without damage to healthy tissue.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Houston, TX, USA
  • Currency USD
  • Founded March 2002
  • Employees 8
  • Website nanospectra.com

Company Summary

Nanospectra (NBI) is commercializing a particle-based therapy for the precise thermal destruction of solid cancer tumors. By allowing the systemically delivered particles to determine the zones of ablation (rather than the placement of an energy source), AuroLase® Therapy can thermally ablate irregularly shaped or inoperable tumors while eliminating damage to healthy adjacent tissue and preserving nearby critical structures.

Team

  • Default avatar
    David K Jorden
    Interim President and CEO

  • Default avatar
    Glenn P Goodrich
    Vice President, COO

    Dr. Goodrich has been with Nanospectra since 2005. He holds a BS in Chemistry and a BA in Computer Science from The University of Iowa and a PhD in Chemistry from Penn State University. He has extensive experience with fabrication and application of nanoparticies, having worked in the field in graduate school and as a post-doctoral fellow under Dr. Naomi Halas at Rice University.

  • Default avatar
    Jon Schwartz
    Director, Clinical Research, PhD

    Dr. Schwartz has been with Nanospectra since 2005. He holds a BS and a MS in Electrical Engineering from Rice University and a PhD in Biophysics from The University of Texas Graduate School of Biomedical Science. He is responsible for the conduct of Nanospectra's clinical pilot studies for the treatment of human cancers. Dr. Schwartz' primary area of research is the development of minimally-invasive tumor ablation techniques using nanoparticles a

Advisors

  • Default avatar
    Kendall, Koenig & Oelsner
    Lawyer
    Unconfirmed
    Default avatar
    Don Payne
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Yellowstone Capital
    Unconfirmed
    Default avatar
    Sentinel Trust Company
    Unconfirmed